| 000 | 01604 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250516211100.0 | ||
| 264 | 0 | _c20140918 | |
| 008 | 201409s 0 0 eng d | ||
| 022 | _a1432-0843 | ||
| 024 | 7 |
_a10.1007/s00280-014-2464-2 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFernandez, C A | |
| 245 | 0 | 0 |
_aSuccessful challenges using native E. coli asparaginase after hypersensitivity reactions to PEGylated E. coli asparaginase. _h[electronic resource] |
| 260 |
_bCancer chemotherapy and pharmacology _cJun 2014 |
||
| 300 |
_a1307-13 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 |
_aAsparaginase _xadministration & dosage |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 |
_aDickeya chrysanthemi _xenzymology |
| 650 | 0 | 4 |
_aDrug Hypersensitivity _xetiology |
| 650 | 0 | 4 |
_aEscherichia coli _xenzymology |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aPolyethylene Glycols _xadverse effects |
| 650 | 0 | 4 |
_aPrecursor Cell Lymphoblastic Leukemia-Lymphoma _xdrug therapy |
| 700 | 1 | _aStewart, E | |
| 700 | 1 | _aPanetta, J C | |
| 700 | 1 | _aWilkinson, M R | |
| 700 | 1 | _aMorrison, A R | |
| 700 | 1 | _aFinkelman, F D | |
| 700 | 1 | _aSandlund, J T | |
| 700 | 1 | _aPui, C H | |
| 700 | 1 | _aJeha, S | |
| 700 | 1 | _aRelling, M V | |
| 700 | 1 | _aCampbell, P K | |
| 773 | 0 |
_tCancer chemotherapy and pharmacology _gvol. 73 _gno. 6 _gp. 1307-13 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s00280-014-2464-2 _zAvailable from publisher's website |
| 999 |
_c23773661 _d23773661 |
||